Bone Biologics (BBLGW) Net Shares Issued and Repurchased (2014 - 2025)
Bone Biologics' (BBLGW) quarterly Net Shares Issued and Repurchased came in at $55461.0 in Q4 2025, up 100.65% year-over-year from $27641.0 in Q4 2024, and down 31.67% quarter-over-quarter from $81165.0 in Q1 2025.
Powered by 
Analysis
Bone Biologics (BBLGW) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Net Shares Issued and Repurchased for 11 consecutive years, with $55461.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 100.65% year-over-year to $55461.0 in Q4 2025; TTM through Dec 2025 was $55461.0, a 100.65% increase from a year earlier, with the FY2025 full-year figure at $55461.0, up 100.65% from the prior year.
- Net Shares Issued and Repurchased was $55461.0 for Q4 2025 at Bone Biologics, down from $81165.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $101166.0 in Q1 2022 and troughed at $887.0 in Q4 2022.
- A 5-year average of $49967.4 and a median of $48847.0 in 2021 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased tumbled 98.18% in 2022 and soared 3552.76% in 2023, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $48847.0 in 2021, then plunged by 98.18% to $887.0 in 2022, then soared by 3552.76% to $32400.0 in 2023, then dropped by 14.69% to $27641.0 in 2024, then soared by 100.65% to $55461.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $55461.0 (Q4 2025), $81165.0 (Q1 2025), and $27641.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.63 Bn | 175.03 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.57 Bn | 122.36 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.86 Bn | 108.04 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.03 Bn | 100.55 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.67 Bn | 63.14 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | - |
| 10 | Bone Biologics | 9.52 Mn | 9.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 55,461.00 |
| Mar 31, 2025 | 81,165.00 |
| Dec 31, 2024 | 27,641.00 |
| Mar 31, 2024 | 45,515.00 |
| Dec 31, 2023 | 32,400.00 |
| Mar 31, 2023 | 56,625.00 |
| Dec 31, 2022 | 887.00 |
| Mar 31, 2022 | 101,166.00 |
| Dec 31, 2021 | 48,847.00 |
| Dec 31, 2019 | 332,512.00 |
| Mar 31, 2019 | 54,909.00 |
| Dec 31, 2018 | 5,222.00 |
| Mar 31, 2018 | 52,218.00 |
| Dec 31, 2017 | 427,064.00 |
| Mar 31, 2017 | 80,341.00 |
| Dec 31, 2016 | 6.36 Mn |
| Mar 31, 2016 | 6.36 Mn |
| Dec 31, 2015 | 5.54 Mn |
| Dec 31, 2014 | 757,977.00 |